BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 28936543)

  • 1. US LI-RADS: ultrasound liver imaging reporting and data system for screening and surveillance of hepatocellular carcinoma.
    Morgan TA; Maturen KE; Dahiya N; Sun MRM; Kamaya A;
    Abdom Radiol (NY); 2018 Jan; 43(1):41-55. PubMed ID: 28936543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of US LI-RADS in the LI-RADS Algorithm.
    Rodgers SK; Fetzer DT; Gabriel H; Seow JH; Choi HH; Maturen KE; Wasnik AP; Morgan TA; Dahiya N; O'Boyle MK; Kono Y; Sirlin CB; Kamaya A
    Radiographics; 2019; 39(3):690-708. PubMed ID: 31059393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ACR Ultrasound Liver Reporting and Data System: Multicenter Assessment of Clinical Performance at One Year.
    Millet JD; Kamaya A; Choi HH; Dahiya N; Murphy PM; Naveed MZ; O'Boyle M; Parra LA; Perez MG; Pirmoazen AM; Rodgers SK; Wasnik AP; Maturen KE
    J Am Coll Radiol; 2019 Dec; 16(12):1656-1662. PubMed ID: 31173745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasound Liver Imaging Reporting and Data System (US LI-RADS): An Overview with Technical and Practical Applications.
    Choi HH; Rodgers SK; Fetzer DT; Wasnik AP; Millet JD; Morgan TA; Dawkins A; Gabriel H; Kamaya A
    Acad Radiol; 2021 Oct; 28(10):1464-1476. PubMed ID: 32718745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening and Surveillance of Hepatocellular Carcinoma: An Introduction to Ultrasound Liver Imaging Reporting and Data System.
    Fetzer DT; Rodgers SK; Harris AC; Kono Y; Wasnik AP; Kamaya A; Sirlin C
    Radiol Clin North Am; 2017 Nov; 55(6):1197-1209. PubMed ID: 28991560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of US Liver Imaging Reporting and Data System Version 2017 in Patients at High Risk for Hepatocellular Carcinoma.
    Son JH; Choi SH; Kim SY; Jang HY; Byun JH; Won HJ; Lee SJ; Lim YS
    Radiology; 2019 Aug; 292(2):390-397. PubMed ID: 31210614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrasound Liver Imaging Reporting and Data System (US LI-RADS) Visualization Score: a reliability analysis on inter-reader agreement.
    Tiyarattanachai T; Bird KN; Lo EC; Mariano AT; Ho AA; Ferguson CW; Chima RS; Desser TS; Morimoto LN; Kamaya A
    Abdom Radiol (NY); 2021 Nov; 46(11):5134-5141. PubMed ID: 34228197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicenter Study of ACR Ultrasound LI-RADS Visualization Scores on Serial Examinations: Implications for Surveillance Strategies.
    Tiyarattanachai T; Fetzer DT; Kamaya A
    AJR Am J Roentgenol; 2022 Sep; 219(3):445-452. PubMed ID: 35383486
    [No Abstract]   [Full Text] [Related]  

  • 9. HCC screening with ultrasound: assessment of quality using ultrasound LI-RADS score.
    King MJ; Lee KM; Rosberger S; Huang HH; Meza GH; Lewis S; Taouli B
    Abdom Radiol (NY); 2023 Jan; 48(1):263-270. PubMed ID: 36243829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrasound Evaluation in Patients at Risk for Hepatocellular Carcinoma.
    Fetzer DT; Rodgers SK; Seow JH; Dawkins AA; Joshi G; Gabriel H; Kamaya A
    Radiol Clin North Am; 2019 May; 57(3):563-583. PubMed ID: 30928078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic Accuracy of CEUS LI-RADS for the Characterization of Liver Nodules 20 mm or Smaller in Patients at Risk for Hepatocellular Carcinoma.
    Huang JY; Li JW; Lu Q; Luo Y; Lin L; Shi YJ; Li T; Liu JB; Lyshchik A
    Radiology; 2020 Feb; 294(2):329-339. PubMed ID: 31793849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic accuracy of contrast-enhanced ultrasound for the differential diagnosis of hepatocellular carcinoma: ESCULAP versus CEUS-LI-RADS.
    Schellhaas B; Görtz RS; Pfeifer L; Kielisch C; Neurath MF; Strobel D
    Eur J Gastroenterol Hepatol; 2017 Sep; 29(9):1036-1044. PubMed ID: 28562394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasound (US) LI-RADS: Outcomes of Category US-3 Observations.
    Sevco TJ; Masch WR; Maturen KE; Mendiratta-Lala M; Wasnik AP; Millet JD
    AJR Am J Roentgenol; 2021 Sep; 217(3):644-650. PubMed ID: 34259543
    [No Abstract]   [Full Text] [Related]  

  • 14. LI-RADS: Past, Present, and Future, From the
    Marks RM; Masch WR; Chernyak V
    AJR Am J Roentgenol; 2021 Feb; 216(2):295-304. PubMed ID: 33052720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrasound LI-RADS Visualization Scores on Surveillance Ultrasound for Hepatocellular Carcinoma: A Systematic Review With Meta-analysis.
    Kang JH; Kim NH; Kim DH; Choi Y; Choi JI
    Ultrasound Med Biol; 2023 Oct; 49(10):2205-2212. PubMed ID: 37517886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. US LI-RADS in surveillance for recurrent hepatocellular carcinoma after curative treatment.
    Huang H; Cheng MQ; He DN; Xian MF; Zeng D; Wu SH; Li CQ; Ruan SM; Li MD; Lin MX; Lu MD; Kuang M; Wang W; Chen LD
    Eur Radiol; 2023 Dec; 33(12):9357-9367. PubMed ID: 37460801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CEUS LI-RADS: algorithm, implementation, and key differences from CT/MRI.
    Wilson SR; Lyshchik A; Piscaglia F; Cosgrove D; Jang HJ; Sirlin C; Dietrich CF; Kim TK; Willmann JK; Kono Y
    Abdom Radiol (NY); 2018 Jan; 43(1):127-142. PubMed ID: 28819825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LI-RADS-CEUS - Proposal for a Contrast-Enhanced Ultrasound Algorithm for the Diagnosis of Hepatocellular Carcinoma in High-Risk Populations.
    Schellhaas B; Wildner D; Pfeifer L; Goertz RS; Hagel A; Neurath MF; Strobel D
    Ultraschall Med; 2016 Dec; 37(6):627-634. PubMed ID: 27486793
    [No Abstract]   [Full Text] [Related]  

  • 19. Associations of Ultrasound LI-RADS Visualization Score With Examination, Sonographer, and Radiologist Factors: Retrospective Assessment in Over 10,000 Examinations.
    Fetzer DT; Browning T; Xi Y; Yokoo T; Singal AG
    AJR Am J Roentgenol; 2022 Jun; 218(6):1010-1020. PubMed ID: 34910539
    [No Abstract]   [Full Text] [Related]  

  • 20. Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules.
    Terzi E; Iavarone M; Pompili M; Veronese L; Cabibbo G; Fraquelli M; Riccardi L; De Bonis L; Sangiovanni A; Leoni S; Zocco MA; Rossi S; Alessi N; Wilson SR; Piscaglia F;
    J Hepatol; 2018 Mar; 68(3):485-492. PubMed ID: 29133247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.